ICU admission N = 382 | Too well to benefit—delayed ICU N = 74 | p-value | |
---|---|---|---|
Age | 65 [58–72] | 66 [59–70] | 0.98 |
Male | 248 (64.9%) | 44 (59.5%) | 0.37 |
Solid malignancy | 244 (63.9%) | 41 (55.4%) | 0.15 |
Hematological malignancy | 136 (35.6%) | 33 (44.6%) | |
Metastatic solid malignancy | 108 (28.3%) | 20 (27%) | 0.83 |
Cancer recurrence | 27 (7.1%) | 5 (6.8%) | 0.92 |
Uncontrolled cancer | 173 (45.4%) | 33 (44.6%) | 0.90 |
CCI | 4 [2–6] | 3 [2–6] | 0.64 |
ECOG PS before hospital | 1 [0–2] | 1 [1–1] | 0.54 |
0 | 108 (28.3%) | 17 (23%) | |
1 | 148 (38.7%) | 39 (52.7%) | |
2 | 81 (21.2%) | 15 (20.3%) | |
3 | 36 (9.4%) | 3 (4.1%) | |
4 | 6 (1.6%) | 0 (0%) | |
Unknown | 3 (0.8%) | 0 (0%) | |
MEWS | 5 [4–7] | 5 [4–7] | 0.13 |
Unknown | 54 (14.1%) | 4 (5.4%) | |
Cancer treatment before ICU Unknown | 343 (90.3%) | 65 (87.8%) | 0.53 |
Immunocompromised | 265 (69.4%) | 49 (66.2%) | 0.55 |
Year ICU consult | 0.66 | ||
2016 | 114 (29.8%) | 22 (29.7%) | |
2017 | 108 (28.3%) | 18 (24.3%) | |
2018 | 99 (25.9%) | 18 (24.3%) | |
2019 | 61 (16%) | 16 (21.6%) | |
Earlier ICU admission before consult | 45 (11.8%) | 8 (10.8%) | 0.82 |
One ICU physician | 158 (41.4%) | 35 (47.3%) | 0.045* |
Two ICU physicians | 176 (46.1%) | 37 (50%) | |
More than two ICU physicians | 48 (12.6%) | 2 (2.7%) | |
One referring physicians | 80 (21.2%) | 19 (26%) | 0.48 |
Two referring physicians | 240 (63.7%) | 41 (56.2%) | |
More than two referring physicians | 57 (15.1%) | 13 (17.8%) | |
Location consult | < 0.001* | ||
Emergency room | 81 (21.2%) | 4 (5.4%) | |
Ward | 190 (49.7%) | 55 (74.3%) | |
Other | 111 (29.1%) | 15 (20.3%) | |
On-hours | 163 (42.7%) | 27 (36.5%) | 0.32 0.62 |
Off-hours | 219 (57.3%) | 47 (63.5%) | |
Weekend | 118 (30.9%) | 25 (33.8%) | |
Consult reason | |||
Shock | 103 (27%) | 5 (6.8%) | < 0.001* |
Respiratory insufficiency | 242 (63.4%) | 50 (67.6%) | 0.49 |
Altered consciousness | 80 (20.9%) | 7 (9.5%) | 0.02* |
Sepsis | 135 (35.3%) | 22 (29.7%) | 0.35 |
Acute kidney injury | 60 (15.7%) | 10 (13.5%) | 0.63 |
High MEWS | 2 (0.5%) | 3 (4.1%) | 0.008* |
Hemodynamic instability | 152(39.8%) | 21 (28.4%) | 0.06 |
Other | 36 (9.4%) | 9 (12.2%) | 0.42 |
Hospital mortality | 148 (38.7%) | 36 (48.6%) | 0.11 |
30-day mortality | 141 (36.9%) | 34 (45.9%) | 0.14 |
90-day mortality | 180 (47.2%) | 43 (58.9%) | 0.07 |
180-day mortality | 206 (54.4%) | 47 (65.3%) | 0.09 |
1 year mortality | 230 (62%) | 54 (75%) | 0.04* |